UCB S.A. Stock
UCB S.A. gained 0.170% compared to yesterday.
So far the community has only identified positive things for UCB S.A. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of UCB S.A. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of UCB S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| UCB S.A. | 0.170% | -3.195% | 4.541% | 44.530% | 52.019% | 57.334% | 71.245% |
| Bayer AG ADR | 6.620% | 3.571% | 7.407% | -49.301% | -15.698% | -45.489% | -52.303% |
| Roche Holding AG ADR | 1.050% | -1.199% | 0.099% | -22.665% | -13.578% | -18.180% | - |
| GSK plc ADR | 1.490% | 5.759% | 5.759% | 20.958% | 20.238% | 2.278% | -11.694% |
Comments
UCB SA (OTCMKTS: UCBJF) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating.
Show more
Ratings data for UCBJF provided by MarketBeat
UCB SA (OTCMKTS: UCBJF) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Show more
Ratings data for UCBJF provided by MarketBeat
